Literature DB >> 11356442

Fatal portal hypertension, liver failure, and mitochondrial dysfunction after HIV-1 nucleoside analogue-induced hepatitis and lactic acidaemia.

A Carr1, A Morey, P Mallon, D Williams, D R Thorburn.   

Abstract

Acute hepatitis with lactic acidosis is a life-threatening but reversible toxic effect on mitochondria of HIV-1 nucleoside-analogue treatment. We report fatal portal hypertension, liver failure, and persistent mitochondrial dysfunction in a man aged 65 years with HIV-1 infection who had recovered from nucleoside-analogue-induced acute hepatitis and lactic acidaemia more than 18 months previously. We believe that symptom free patients who receive nucleoside-analogue therapy should have hepatic function constantly monitored, especially those with past or present lactic acidaemia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11356442     DOI: 10.1016/S0140-6736(00)04579-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  11 in total

1.  Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.

Authors:  Sílvia Vilarinho; Sinan Sari; Güldal Yilmaz; Amy L Stiegler; Titus J Boggon; Dhanpat Jain; Gulen Akyol; Buket Dalgic; Murat Günel; Richard P Lifton
Journal:  Hepatology       Date:  2016-03-31       Impact factor: 17.425

2.  The chemical bases of the various AIDS epidemics: recreational drugs, anti-viral chemotherapy and malnutrition.

Authors:  Peter Duesberg; Claus Koehnlein; David Rasnick
Journal:  J Biosci       Date:  2003-06       Impact factor: 1.826

Review 3.  Triple nucleoside reverse transcriptase inhibitor therapy in children.

Authors:  Jennifer Handforth; Mike Sharland
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

4.  Lactic acidosis and abnormal liver function in advanced HIV disease.

Authors:  M Shahmanesh; J Cartledge; R Miller
Journal:  Sex Transm Infect       Date:  2002-04       Impact factor: 3.519

5.  Pharmacokinetics and dose-range finding toxicity of a novel anti-HIV active integrase inhibitor.

Authors:  Vasu Nair; Maurice Okello; Sanjay Mishra; Jon Mirsalis; Kathleen O'Loughlin; Yu Zhong
Journal:  Antiviral Res       Date:  2014-05-10       Impact factor: 5.970

Review 6.  Lactic acidosis in HIV infected patients: a systematic review of published cases.

Authors:  A Arenas-Pinto; A D Grant; S Edwards; I V D Weller
Journal:  Sex Transm Infect       Date:  2003-08       Impact factor: 3.519

7.  Pilot, randomized study assessing safety, tolerability and efficacy of simplified LPV/r maintenance therapy in HIV patients on the 1 PI-based regimen.

Authors:  Pedro Cahn; Julio Montaner; Patrice Junod; Patricia Patterson; Alejandro Krolewiecki; Jaime Andrade-Villanueva; Isabel Cassetti; Juan Sierra-Madero; Arnaldo David Casiró; Raul Bortolozzi; Sergio Horacio Lupo; Nadia Longo; Emmanouil Rampakakis; Nabil Ackad; John S Sampalis
Journal:  PLoS One       Date:  2011-08-19       Impact factor: 3.240

8.  Enhanced hepatic respiratory capacity and altered lipid metabolism support metabolic homeostasis during short-term hypoxic stress.

Authors:  Katie A O'Brien; Ben D McNally; Alice P Sowton; Antonio Murgia; James Armitage; Luke W Thomas; Fynn N Krause; Lucas A Maddalena; Ian Francis; Stefan Kavanagh; Dominic P Williams; Margaret Ashcroft; Julian L Griffin; Jonathan J Lyon; Andrew J Murray
Journal:  BMC Biol       Date:  2021-12-15       Impact factor: 7.364

9.  Antiretroviral Therapy-associated Serious and Life-threatening Toxicities.

Authors:  Alice K. Pau
Journal:  Curr Infect Dis Rep       Date:  2003-10       Impact factor: 3.663

10.  Effect of coadministration of neurovite and Lamivudine on the histomorphology of the cerebellum of wistar rats.

Authors:  A I Peter; M B Ekong; K Davies; O O Azu; R B Bassey; L O Ugwu; I U Umoh
Journal:  ISRN Neurosci       Date:  2014-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.